Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Marlene Icenhower, BSN, JD, CPHRM
Marlene Icenhower is a senior risk specialist at medical professional liability insurance company Coverys and a fellow of the American Society for Healthcare Risk Management (FASHRM). She graduated from St. Louis University with a Bachelor of Science in Nursing (1984) and a Juris Doctor (law, 1987).